Research map: Early Clinical Response Predicts Treatment Persistence in Advanced Therapy–naive Atopic Dermatitis

Back to the article

Papers in this map

  1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis · Eric Lawrence Simpson · 2016 · 2103 citations · Cited by this paper
  2. Chronic Pain and Pain Tolerance in Psoriasis: A Cross-sectional Study of Three Population-based Cohorts in the Netherlands and Norway · 2026 · Related
  3. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)* · Andreas Wollenberg · 2020 · 628 citations · Cited by this paper
  4. Widespread Erythematous Vesiculobullea: A Quiz · 2026 · Related
  5. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials · Emma Guttman‐Yassky · 2021 · 575 citations · Cited by this paper
  6. Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study · 2026 · Related
  7. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children · Andreas Wollenberg · 2020 · 481 citations · Cited by this paper
  8. Increased Mortality in Patients with Bullous Pemphigoid: A Nationwide Population-based Cohort Study of 5,738 Patients in Sweden · 2026 · Related
  9. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis · Jonathan I. Silverberg · 2023 · 343 citations · Cited by this paper
  10. Chronic Pruritus in Predialysis Chronic Kidney Disease: Prevalence, Phenotype and Temporal Patterns in a Prospective Cohort · 2026 · Related
  11. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials · Jochen M. Schmitt · 2014 · 321 citations · Cited by this paper
  12. Polymorphic Skin Rash and Fatigue in a Patient with Diabetes Mellitus: A Quiz · 2026 · Related
  13. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study · Yael A. Leshem · 2015 · 293 citations · Cited by this paper
  14. Clinical and Pathological Predictors of Unfavourable Outcomes in Thin and In Situ Melanomas: A Retrospective Cohort Study from Taiwan · 2026 · Related
  15. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies · Dawn Marie R. Davis · 2023 · 257 citations · Cited by this paper
  16. Real-world Clinical Efficacy and Patient-reported Treatment Satisfaction of Nemolizumab Treatment in Prurigo Nodularis · 2026 · Related
  17. Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry · Lieneke F.M. Ariëns · 2019 · 151 citations · Cited by this paper
  18. Reported Penicillin Allergy Affects the Length of Hospital Stay in Patients with Erysipelas · 2026 · Related
  19. Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies · Marjolein S. de Bruin-Weller · 2021 · 150 citations · Cited by this paper
  20. Joint Relationship of Cardiovascular-kidney-metabolic Syndrome and Psoriasis with All-cause and Cause-specific Mortality in Adults: A Population-based Analysis · 2026 · Related
  21. Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets · David Prieto‐Merino · 2021 · 140 citations · Cited by this paper
  22. Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls · Juul M. P. A. van den Reek · 2015 · 136 citations · Cited by this paper
  23. Systemic Immunomodulatory Treatments for Atopic Dermatitis · Aaron Mark Drucker · 2024 · 88 citations · Cited by this paper
  24. Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors · Richard W. Kim · 2024 · 58 citations · Cited by this paper
  25. Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population-based cohort study · Serena Yun‐Chen Tsai · 2024 · 54 citations · Cited by this paper
  26. Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis · Lotte S. Spekhorst · 2022 · 50 citations · Cited by this paper
  27. Expert consensus on the persistence of biological treatments in moderate‐to‐severe psoriasis · P. de la Cueva Dobao · 2019 · 37 citations · Cited by this paper
  28. Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily Practice · Anne R. Schlösser · 2025 · 24 citations · Cited by this paper
  29. Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database · Nathaniel Hendrix · 2020 · 10 citations · Cited by this paper
  30. Drug Survival and Predictors of Systemic Treatment Outcome in Atopic Dermatitis: Data From a Nationwide Swedish Cohort · Patrik Jonsson · 2025 · 10 citations · Cited by this paper
  31. Drug Survival in Atopic Dermatitis: Comparison of Biologics and JAK Inhibitors in the BioDay Registry · Lian F. van der Gang · 2025 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)